🇺🇸 FDA

Company profile · Sponsor

Gain

Gain Therapeutics

GANX · NYSE pharma BETHESDA, MD, USA
Pipeline
3
Drugs
0
Patents
8

Quick answer

Gain (GANX) is a pharma company. headquartered in BETHESDA, MD, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker GANX
Exchange NYSE
Company type pharma
Headquarters BETHESDA, MD, USA
SEC CIK 0001819411

Pipeline (3)

Search pipeline →

  1. Low Dose GT-02287

    Gain

    Parkinson Disease

    phase 2 small molecule active

    1 trial

  2. GT-02287

    Gain

    Parkinson Disease

    phase 1 small molecule active

    1 trial

  3. Envita Stories Methodology in Long-term care Centres for old adults

    Gain

    Long-term Care Centres for Old Adults Users

    other active

    1 trial

Patents (8)

Search patents →

  1. US 12370232

    Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12201701

    Vegetable oil-derived contrast agent with high stability and preparation method thereof

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11730178

    Extraction method

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11311581

    Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11020365

    Mixture of fatty acids for use in the treatment of inflammatory pathologies

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10960000

    Abuse resistant pharmaceutical compositions

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10646523

    Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10213389

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Gain?

Gain (GANX) is a pharma company. headquartered in BETHESDA, MD, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Gain sponsor?

We track 3 ClinicalTrials.gov-linked programs for Gain, including Low Dose GT-02287 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Gain company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.